0001104659-25-059385.txt : 20250613 0001104659-25-059385.hdr.sgml : 20250613 20250613162359 ACCESSION NUMBER: 0001104659-25-059385 CONFORMED SUBMISSION TYPE: 253G2 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250613 DATE AS OF CHANGE: 20250613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Global Health Solutions, Inc CENTRAL INDEX KEY: 0002023016 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 320456090 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 253G2 SEC ACT: 1933 Act SEC FILE NUMBER: 024-12562 FILM NUMBER: 251046936 BUSINESS ADDRESS: STREET 1: 250 NORTH WESTLAKE BLVD. STREET 2: #210 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 BUSINESS PHONE: 8185644011 MAIL ADDRESS: STREET 1: 250 N. WESTLAKE BLVD. STREET 2: #210 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 253G2 1 tm2518005d1_253g2.htm 253G2

Filed pursuant to Rule 253(g)(2)

File No. 024-12562

SUPPLMENT DATED JUNE 13, 2025

GLOBAL HEALTH SOLUTIONS, INC. , dba Turn Therapeutics

EXPLANATORY NOTE

This document supplements, and should be read in conjunction with, the offering statement on Form 1-A filed by Global Health Solutions, Inc. (the “Company”) and amendments and supplements thereto. The offering statement was qualified by the U.S. Securities and Exchange Commission on March 31, 2025. Unless otherwise defined in this supplement, capitalized terms used in this supplement shall have the same meanings as set forth in the Offering Circular.

The Offering Circular is available here.

The purpose of this supplement is to announce the following change to the offering statement and any supplements, effective immediately:

Offering Termination Date

The purpose of this supplement is to announce that the Regulation A offering conducted by the Company will terminate on June 27, 2025 (the "Termination Date”). No further subscriptions will be accepted after 11:59 pm PT on June 27, 2025. Subscriptions in the offering will be accepted up to that time and processed as promptly as possible. None of the terms of the offering have been changed. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.